Literature DB >> 6125919

Huntington disease: functional capacities in patients treated with neuroleptic and antidepressant drugs.

I Shoulson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 6125919     DOI： 10.1212/wnl.31.10.1333

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  54 in total

1.  Clozapine versus placebo in Huntington's disease: a double blind randomised comparative study.

Authors:  J P van Vugt; S Siesling; M Vergeer; E A van der Velde; R A Roos
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-07       Impact factor: 10.154

2.  Cerebral correlates of disturbed executive function and memory in survivors of severe closed head injury: a SPECT study.

Authors:  G Goldenberg; W Oder; J Spatt; I Podreka
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-05       Impact factor: 10.154

3.  Analysis of potential transcriptomic biomarkers for Huntington's disease in peripheral blood.

Authors:  Heike Runne; Alexandre Kuhn; Edward J Wild; Wirahpati Pratyaksha; Mark Kristiansen; Jeremy D Isaacs; Etienne Régulier; Mauro Delorenzi; Sarah J Tabrizi; Ruth Luthi-Carter
Journal:  Proc Natl Acad Sci U S A       Date:  2007-08-27       Impact factor: 11.205

4.  Decreased N-acetyl-aspartate/choline ratio and increased lactate in the frontal lobe of patients with Huntington's disease: a proton magnetic resonance spectroscopy study.

Authors:  L Harms; H Meierkord; G Timm; L Pfeiffer; A C Ludolph
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-01       Impact factor: 10.154

Review 5.  Huntington disease: natural history, biomarkers and prospects for therapeutics.

Authors:  Christopher A Ross; Elizabeth H Aylward; Edward J Wild; Douglas R Langbehn; Jeffrey D Long; John H Warner; Rachael I Scahill; Blair R Leavitt; Julie C Stout; Jane S Paulsen; Ralf Reilmann; Paul G Unschuld; Alice Wexler; Russell L Margolis; Sarah J Tabrizi
Journal:  Nat Rev Neurol       Date:  2014-03-11       Impact factor: 42.937

Review 6.  An overview of psychiatric symptoms in Huntington's disease.

Authors:  K E Anderson; K S Marder
Journal:  Curr Psychiatry Rep       Date:  2001-10       Impact factor: 5.285

7.  Bicaudate diameter--the most specific and simple CT parameter in the diagnosis of Huntington's disease.

Authors:  T Stober; W Wussow; K Schimrigk
Journal:  Neuroradiology       Date:  1984       Impact factor: 2.804

8.  Effect of neuroleptic treatment on involuntary movements and motor performances in Huntington's disease.

Authors:  F Girotti; F Carella; G Scigliano; M P Grassi; P Soliveri; P Giovannini; E Parati; T Caraceni
Journal:  J Neurol Neurosurg Psychiatry       Date:  1984-08       Impact factor: 10.154

9.  Influence of intensive multifunctional neurorehabilitation on neuronal oxidative damage in patients with Huntington's disease.

Authors:  Irene Ciancarelli; Daniela De Amicis; Caterina Di Massimo; Giorgio Sandrini; Caterina Pistarini; Antonio Carolei; Maria Giuliana Tozzi Ciancarelli
Journal:  Funct Neurol       Date:  2015 Jan-Mar

10.  Responsiveness to Change Over Time: An Examination of the Neuro-QoL Social Function Measures in Persons with Huntington's Disease.

Authors:  Noelle E Carlozzi; Nicholas R Boileau; Elizabeth A Hahn; Stacey K Barton; David Cella; Michael K McCormack; Rebecca E Ready
Journal:  J Huntingtons Dis       Date:  2020
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.